Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01853592 · ClinicalTrials.gov registry record
Gadofosveset Trisodium for Heart Imaging Studies
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 30
- Enrollment target
NCT01853592 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 30 participants.
The verdict
NCT01853592 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Background: \- Magnetic resonance imaging (MRI) is type of imaging study that uses magnetic fields and radio waves to take pictures of the body. To help the images show up more clearly, a contrast agent is injected into a vein. Researchers are interested in finding contrast agents that can help show problems with the blood vessels around the heart. They want to test an agent called Gadofosveset Trisodium to see how it works in MRI scans. Objectives: \- To test the effectiveness of Gadofosveset Trisodium as a contrast agent in heart MRI scans. Eligibility: \- Healthy volunteers between 18 and 45 years of age. Design: * Participants will be screened with a physical exam and medical history. They will provide blood samples before the scanning sessions. * Participants will have an MRI scan after the screening visit. They will have a dose of the contrast scan before the study. * Participants will return for one additional MRI scan within 1 to 2 months of each scan. Different doses of the contrast agent will be used for each scan. * An additional blood sample will be collected within 1 week of the second MRI scan.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2013-03-08 |
| Est. Completion | 2016-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01853592
The ClinicalTrials.gov registry entry for NCT01853592 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01853592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01853592 about?
NCT01853592 is a clinical study titled "Gadofosveset Trisodium for Heart Imaging Studies". Background: \- Magnetic resonance imaging (MRI) is type of imaging study that uses magnetic fields and radio waves to take pictures of the body. To help the images show up more clearly, a contrast agent is injected into a vein. Researchers are interested in finding contrast agents that can help sho...
What is the current status of trial NCT01853592?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2013-03-08. Estimated completion is 2016-12-13.
Who is sponsoring clinical trial NCT01853592?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.